UBXN1

protein-coding

UBX domain protein 1, the group of UBX domain containing

Gene summary

Enables several functions, including enzyme binding activity; polyubiquitin modification-dependent protein binding activity; and proteasome regulatory particle binding activity. Involved in negative regulation of protein metabolic process. Located in cytosol and endoplasmic reticulum. Part of VCP-NPL4-UFD1 AAA ATPase complex. [provided by Alliance of Genome Resources, Jun 2026]

MANE transcript

NM_001286077.2

Inheritance

—

ClinVar variants

U:41B:3

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 0.17

Max pathogenic AF

—

Genomic locus

chr11:62,676,498-62,679,117

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~2.6 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to UBXN1 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 44
not providedTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001286077.2. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
2
missense
37
clinvar
1
clinvar
38
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
4
clinvar
4
Total00413044
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 31 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001286077.2RefSeqNP_001273006.19MANE Select
ENST00000301935.10EnsemblENSP00000303991.59MANE Select
NM_001286078.2RefSeqNP_001273007.17Standard
NM_015853.5RefSeqNP_056937.28Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Post-translational protein modification
  • Metabolism of proteins
  • Asparagine N-linked glycosylation
  • N-glycan trimming in the ER and Calnexin/Calreticulin cycle

Biological Process

  • protein folding
  • viral process
  • negative regulation of protein ubiquitination
  • negative regulation of proteasomal ubiquitin-dependent protein catabolic process
  • proteasome-mediated ubiquitin-dependent protein catabolic process

Molecular Function

  • protein binding
  • polyubiquitin modification-dependent protein binding
  • ubiquitin protein ligase binding
  • K48-linked polyubiquitin modification-dependent protein binding
  • ubiquitin binding

Cellular Component

  • nucleus
  • cytoplasm
  • endoplasmic reticulum
  • cytosol
  • dendrite

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000294119
Coding exons
8
Length
2598
Individuals with no LoFs
125739
Homozygous LoFs
0
Heterozygous LoFs
9
Defined
125748
p
0.0000358
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.8381601930.8300.00001161983
Missense (PolyPhen)5577.160.7128814
Synonymous-1.258268.81.190.00000352637
Loss of Function3.20317.40.1728.50e-7194

Population LoF Frequency

PopulationCAFp-valueStatus
African00.0absent
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian00.0absent
Finnish0.0000950.000092rare
European (Non-Finnish)0.0000270.000026rare
South Asian0.0000650.000065rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Ubiquitin-binding protein that plays a role in the modulation of innate immune response. Blocks both the RIG-I-like receptors (RLR) and NF-kappa-B pathways. Following viral infection, UBXN1 is induced and recruited to the RLR component MAVS. In turn, interferes with MAVS oligomerization, and disrupts the MAVS/TRAF3/TRAF6 signalosome. This function probably serves as a brake to prevent excessive RLR signaling (PubMed:23545497). Interferes with the TNFalpha-triggered NF-kappa-B pathway by interacting with cellular inhibitors of apoptosis proteins (cIAPs) and thereby inhibiting their recruitment to TNFR1 (PubMed:25681446). Prevents also the activation of NF-kappa-B by associating with CUL1 and thus inhibiting NF-kappa-B inhibitor alpha/NFKBIA degradation that remains bound to NF-kappa-B (PubMed:28152074). Interacts with the BRCA1-BARD1 heterodimer and regulates its activity. Specifically binds 'Lys-6'-linked polyubiquitin chains. Interaction with autoubiquitinated BRCA1 leads to the inhibition of the E3 ubiquitin-protein ligase activity of the BRCA1-BARD1 heterodimer (PubMed:20351172). Component of a complex required to couple deglycosylation and proteasome-mediated degradation of misfolded proteins in the endoplasmic reticulum that are retrotranslocated in the cytosol. {ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:23545497, ECO:0000269|PubMed:25681446, ECO:0000269|PubMed:28152074}.;

Recessive Scores

pRec
0.118

Intolerance Scores

LoFtool
0.415
RVIS EVS
0.48
RVIS percentile EVS
79.04

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
S
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.567

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.